Jessamy Tiffen

Dr. Jessamy Tiffen is an Australian Scientist and senior researcher in the Melanoma Immunology and Oncology Program at the Centenary Institute of Cancer Medicine and Cell Biology at the University of Sydney, New South Wales, Australia.[1]

Early life

Tiffen's grandfather was a microbiologist and her interest in science stems from conversations with her grandfather growing up.[1]

Career

Tiffen's work focuses on melanoma, and why some melanomas respond to treatment in certain individuals but others do not.[1][2]

Tiffen co-authored a study in 2016 which identified a drug that could be effective in fighting melanoma,[3] and is currently researching a new treatment strategy with Dr. Hsin-Yi Tseng that involves inducing melanoma cellular self-destruction.[4]

References
  1. "International Day of Women and Girls in Science: Highlighting Dr Jessamy Tiffen, Centenary Institute". GetSTEM. 2020-02-10. Retrieved 2020-03-20.
  2. "Discovery unlocks secrets behind cancer drug resistance". ScienceDaily. Retrieved 2020-03-20.
  3. "Researchers Identify Drug That Could Treat Melanoma | Newsroom". news.ucmerced.edu. Retrieved 2020-03-20.
  4. "Triggering melanoma cell death to fight cancer with its own 'suicide switch'". medicalxpress.com. Retrieved 2020-07-01.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.